HealthcareTransaction activity across the Healthcare sector remains strong.
Deal volumes are being driven by new technology, new care delivery models, new investors entering the market and the need for more to be achieved from the NHS budget.
At Catalyst we segment the sector into three key areas – Healthcare Services, Pharmaceuticals (products and services) and Medtech (devices and supplies). Within these we are seeing strong interest and have deal experience in:
- Contract research organisation services
- Domiciliary and specialist care
- Generic pharmaceuticals
- Primary and Community Care services
- Telecare devices and services
The UK’s decision to leave the EU represents a major opportunity for the country’s dynamic and world-leading pharmaceutical sector – despite warnings that Brexit could prompt pharma companies to quit the UK.
Adobe Acrobat file - 0.2 mb
The inaugural Catalyst Pharma Fast 50, our list of the 50 fastest-growing privately owned pharmaceutical companies in the UK in 2016
Adobe Acrobat file - 3.4 mb